The Oncology Institute, Inc. (TOI) Q2 2024 Earnings
TOI·Reported August 13, 2024·After market close
The Oncology Institute, Inc. reported Q2 2024 revenue of $98.6M, missed analyst consensus of $103.3M by $4.7M. Diluted EPS came in at $-0.17, missed the $-0.10 consensus by $0.07.
Revenue
$98.6Mmissed by $4.7M
Consensus: $103.3MDiluted EPS
$-0.17missed by $0.07
Consensus: $-0.10
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about The Oncology Institute, Inc.'s Q2 2024 earnings report.
The Oncology Institute, Inc. (TOI) reported Q2 2024 earnings on August 13, 2024 after market close.
The Oncology Institute, Inc. reported revenue of $98.6M and diluted EPS of $-0.17 for Q2 2024.
Revenue missed the consensus estimate of $103.3M by $4.7M. EPS missed the consensus estimate of $-0.10 by $0.07.
You can read the 10-Q periodic report (0001799191-24-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.